Norinchukin Bank The Has $28.85 Million Stock Holdings in Mettler-Toledo International Inc. (NYSE:MTD)

Norinchukin Bank The boosted its holdings in shares of Mettler-Toledo International Inc. (NYSE:MTDGet Rating) by 2.2% in the fourth quarter, Holdings Channel reports. The firm owned 16,998 shares of the medical instruments supplier’s stock after purchasing an additional 370 shares during the quarter. Norinchukin Bank The’s holdings in Mettler-Toledo International were worth $28,849,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also made changes to their positions in MTD. CVA Family Office LLC bought a new position in Mettler-Toledo International during the fourth quarter worth about $25,000. Eagle Bay Advisors LLC lifted its stake in Mettler-Toledo International by 44.4% during the third quarter. Eagle Bay Advisors LLC now owns 26 shares of the medical instruments supplier’s stock worth $36,000 after purchasing an additional 8 shares during the period. Amplius Wealth Advisors LLC bought a new position in Mettler-Toledo International during the fourth quarter worth about $39,000. Moors & Cabot Inc. bought a new position in Mettler-Toledo International during the third quarter worth about $51,000. Finally, Sageworth Trust Co of South Dakota bought a new position in Mettler-Toledo International during the fourth quarter worth about $56,000. Hedge funds and other institutional investors own 93.88% of the company’s stock.

In related news, CFO Shawn Vadala sold 1,846 shares of the business’s stock in a transaction dated Friday, February 25th. The stock was sold at an average price of $1,445.00, for a total value of $2,667,470.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Peter Aggersbjerg sold 694 shares of the business’s stock in a transaction dated Tuesday, February 15th. The stock was sold at an average price of $1,424.29, for a total value of $988,457.26. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 17,540 shares of company stock valued at $24,552,512. Company insiders own 2.80% of the company’s stock.

MTD has been the subject of a number of analyst reports. StockNews.com assumed coverage on shares of Mettler-Toledo International in a research note on Thursday, March 31st. They set a “buy” rating for the company. Wells Fargo & Company upgraded shares of Mettler-Toledo International from an “equal weight” rating to an “overweight” rating and cut their target price for the company from $1,600.00 to $1,410.00 in a research note on Monday, April 25th. The Goldman Sachs Group lowered shares of Mettler-Toledo International from a “neutral” rating to a “sell” rating and set a $1,240.00 price target for the company. in a report on Thursday, March 10th. Finally, Robert W. Baird lifted their target price on shares of Mettler-Toledo International from $1,531.00 to $1,595.00 in a report on Friday, February 11th. One investment analyst has rated the stock with a sell rating, one has issued a hold rating and three have issued a buy rating to the company’s stock. Based on data from MarketBeat, the company currently has a consensus rating of “Hold” and a consensus target price of $1,449.25.

MTD traded up $33.72 during trading on Thursday, reaching $1,213.12. 152,108 shares of the stock were exchanged, compared to its average volume of 132,074. The stock has a market cap of $27.58 billion, a P/E ratio of 35.63, a price-to-earnings-growth ratio of 1.80 and a beta of 1.07. Mettler-Toledo International Inc. has a twelve month low of $1,168.31 and a twelve month high of $1,714.75. The stock’s 50 day moving average price is $1,332.33 and its two-hundred day moving average price is $1,451.88. The company has a debt-to-equity ratio of 9.22, a quick ratio of 0.75 and a current ratio of 1.11.

Mettler-Toledo International (NYSE:MTDGet Rating) last issued its earnings results on Thursday, May 5th. The medical instruments supplier reported $7.87 earnings per share for the quarter, topping analysts’ consensus estimates of $7.28 by $0.59. The business had revenue of $897.80 million for the quarter, compared to the consensus estimate of $868.08 million. Mettler-Toledo International had a net margin of 20.82% and a return on equity of 471.45%. The firm’s revenue for the quarter was up 11.6% on a year-over-year basis. During the same period in the previous year, the company earned $6.56 earnings per share. Equities research analysts predict that Mettler-Toledo International Inc. will post 38.38 earnings per share for the current fiscal year.

About Mettler-Toledo International (Get Rating)

Mettler-Toledo International Inc engages in the manufacture and supply of precision instruments and services worldwide. It operates in five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company's laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.

Further Reading

Want to see what other hedge funds are holding MTD? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Mettler-Toledo International Inc. (NYSE:MTDGet Rating).

Institutional Ownership by Quarter for Mettler-Toledo International (NYSE:MTD)

Receive News & Ratings for Mettler-Toledo International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mettler-Toledo International and related companies with MarketBeat.com's FREE daily email newsletter.